Evidence map›Paper›PMID 37418385›Full record

ArticlePloS one2023

Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.

Marijn Muurling, Anna M G Pasmooij, Ivan Koychev, Dora Roik, Lutz Froelich, Emilia Schwertner, Dorota Religa, Carla Abdelnour, Mercè Boada, Monica Almici and 16 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 12 countries.

Marijn MuurlingAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.ORCID 0000-0001-9397-4602
Anna M G PasmooijDutch Medicines Evaluation Board, Utrecht, Netherlands.
Ivan KoychevDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Dora RoikDepartment of Geriatric Psychiatry, Central Institute for Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Lutz FroelichDepartment of Geriatric Psychiatry, Central Institute for Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
Emilia SchwertnerDivision of Clinical Geriatrics, Department of Neurobiology, Department of Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Dorota ReligaDivision of Clinical Geriatrics, Department of Neurobiology, Department of Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Carla AbdelnourDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States of America.
Mercè BoadaAce Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.ORCID 0000-0003-2617-3009
Monica AlmiciLaboratory Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Samantha GalluzziLaboratory Alzheimer's Neuroimaging & Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Sandra CardosoFaculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Alexandre de MendonçaFaculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Andrew P OwensInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Sajini KuruppuInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Martha Therese GjestsenCentre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.ORCID 0000-0002-8762-3109
Ioulietta LazarouInformation Technologies Institute, Center for Research and Technology Hellas (CERTH-ITI), Thessaloniki, Greece.
Mara GkiokaLaboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh), Balkan Center, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Magda TsolakiLaboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh), Balkan Center, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ana DiazAlzheimer Europe, Luxembourg, Luxembourg.
Dianne GoveAlzheimer Europe, Luxembourg, Luxembourg.
Pieter Jelle VisserAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
Dag AarslandInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Federica LuciveroEthox and Welcome Centre for Ethics and Humanities, University of Oxford, Oxford, United Kingdom.
Casper de BoerAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
RADAR-AD Consortium
King's College London · GBAlzheimer Europe · LUAmsterdam Neuroscience · NLAristotle University of Thessaloniki · GRCentro San Giovanni di Dio Fatebenefratelli · ITHeidelberg University · DEKarolinska Institutet · SEUniversity of Lisbon · PTUniversity of Oxford · GBInformation Technologies Institute · GRInstituto de Salud Carlos III · ESKarolinska University Hospital · SEMedicines Evaluation Board · NLStanford University · USStavanger University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClinical research with remote monitoring technologies (RMTs) has multiple advantages over standard paper-pencil tests, but also raises several ethical concerns. While several studies have addressed the issue of governance of big data in clinical research from the legal or ethical perspectives, the viewpoint of local research ethics committee (REC) members is underrepresented in the current literature. The aim of this study is therefore to find which specific ethical challenges are raised by RECs in the context of a large European study on remote monitoring in all syndromic stages of Alzheimer's disease, and what gaps remain.

methodsDocuments describing the REC review process at 10 sites in 9 European countries from the project Remote Assessment of Disease and Relapse-Alzheimer's Disease (RADAR-AD) were collected and translated. Main themes emerging in the documents were identified using a qualitative analysis approach.

resultsFour main themes emerged after analysis: data management, participant's wellbeing, methodological issues, and the issue of defining the regulatory category of RMTs. Review processes differed across sites: process duration varied from 71 to 423 days, some RECs did not raise any issues, whereas others raised up to 35 concerns, and the approval of a data protection officer was needed in half of the sites. DISCUSSION: The differences in the ethics review process of the same study protocol across different local settings suggest that a multi-site study would benefit from a harmonization in research ethics governance processes. More specifically, some best practices could be included in ethical reviews across institutional and national contexts, such as the opinion of an institutional data protection officer, patient advisory board reviews of the protocol and plans for how ethical reflection is embedded within the study.

Indexed as

Alzheimer DiseaseEthics Committees, ResearchEthical ReviewEthics, ResearchEuropeHumans

Identifiers

PMID37418385
PMCPMC10328231
OpenAlexW4383531840

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.